{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:26:38Z","timestamp":1781731598791,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93103-4","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:34:46Z","timestamp":1741782886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Considerations for repetitive intrathecal procedures in long-term nusinersen treatment for non-ambulatory spinal muscular atrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Hong Seon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mock","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"93103_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn, J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med. Genet. 15, 409\u2013413 (1978).","journal-title":"J. Med. Genet."},{"key":"93103_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ajmg.10425","volume":"110","author":"S Ogino","year":"2002","unstructured":"Ogino, S., Leonard, D. G., Rennert, H., Ewens, W. J. & Wilson, R. B. Genetic risk assessment in carrier testing for spinal muscular atrophy. Am. J. Med. Genet. 110, 301\u2013307 (2002).","journal-title":"Am. J. Med. Genet."},{"key":"93103_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman, E. A. et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: Clinical laboratory analysis of >72,400 specimens. Eur. J. Hum. Genet. 20, 27\u201332 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"93103_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford, T. O. & Pardo, C. A. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3, 97\u2013110 (1996).","journal-title":"Neurobiol Dis"},{"key":"93103_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"93103_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T. & Finkel, R. S. Spinal muscular atrophy. Nat. Rev. Dis. Prim. 8, 52 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"93103_CR7","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","volume":"26","author":"NK Singh","year":"2006","unstructured":"Singh, N. K., Singh, N. N., Androphy, E. J. & Singh, R. N. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol. Cell Biol. 26, 1333\u20131346 (2006).","journal-title":"Mol. Cell Biol."},{"key":"93103_CR8","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini, M. A. et al. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci. Transl. Med. 3, 72ra18 (2011).","journal-title":"Sci. Transl. Med."},{"key":"93103_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"93103_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13023-023-02769-4","volume":"18","author":"A \u0141usakowska","year":"2023","unstructured":"\u0141usakowska, A. et al. Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: A real-world experience. Orphanet. J. Rare Dis. 18, 230 (2023).","journal-title":"Orphanet. J. Rare Dis."},{"key":"93103_CR11","first-page":"S3","volume":"24","author":"VK Rao","year":"2018","unstructured":"Rao, V. K., Kapp, D. & Schroth, M. Gene therapy for spinal muscular atrophy: An emerging treatment option for a devastating disease. J. Manag. Care Spec. Pharm. 24, S3-s16 (2018).","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"93103_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nbt.3784","volume":"35","author":"O Khorkova","year":"2017","unstructured":"Khorkova, O. & Wahlestedt, C. Oligonucleotide therapies for disorders of the nervous system. Nat. biotechnol. 35, 249\u2013263 (2017).","journal-title":"Nat. biotechnol."},{"key":"93103_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold, W. D., Kassar, D. & Kissel, J. T. Spinal muscular atrophy: Diagnosis and management in a new therapeutic era. Muscle Nerve. 51, 157\u2013167 (2015).","journal-title":"Muscle Nerve."},{"key":"93103_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00415-018-9124-0","volume":"266","author":"CD Wurster","year":"2019","unstructured":"Wurster, C. D. et al. Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients. J. Neurol. 266, 183\u2013194 (2019).","journal-title":"J. Neurol."},{"key":"93103_CR15","first-page":"194","volume":"24","author":"EE Neil","year":"2019","unstructured":"Neil, E. E. & Bisaccia, E. K. Nusinersen: A novel antisense oligonucleotide for the treatment of spinal muscular atrophy. J. Pediatr. Pharmacol. Ther. 24, 194\u2013203 (2019).","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"93103_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.nmd.2013.06.370","volume":"23","author":"IJ de Groot","year":"2013","unstructured":"de Groot, I. J. et al. 184th enmc international workshop: Pain and fatigue in neuromuscular disorders: 20\u201322 May 2011, naarden, the netherlands. Neuromuscul. Disord. 23, 1028\u20131032 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"93103_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00415-022-11351-0","volume":"270","author":"E Sagerer","year":"2023","unstructured":"Sagerer, E., Wirner, C., Schoser, B. & Wenninger, S. Nociceptive pain in adult patients with 5q-spinal muscular atrophy type 3: A cross-sectional clinical study. J. Neurol. 270, 250\u2013261 (2023).","journal-title":"J. Neurol."},{"key":"93103_CR18","unstructured":"Middlebrook, M. Disease severity, self-stigma of disability, and positive coping skills in adults with spinal muscular atrophy (SMA) (College of Saint Elizabeth, 2023)."},{"key":"93103_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejpn.2022.12.006","volume":"42","author":"PK Panda","year":"2023","unstructured":"Panda, P. K., Ramachandran, A., Verma, P. K. & Sharawat, I. K. Behavioral problems in infants and young children with spinal muscular atrophy and their siblings: A cross-sectional study. Eur. J. Paediatr. Neurol. 42, 47\u201352 (2023).","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"93103_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/jamaneurol.2014.3974","volume":"72","author":"AE Monserrate","year":"2015","unstructured":"Monserrate, A. E. et al. Factors associated with the onset and persistence of post-lumbar puncture headache. JAMA Neurol. 72, 325\u2013332 (2015).","journal-title":"JAMA Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93103-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T22:27:08Z","timestamp":1741818428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93103-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93103"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93103-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors hereby consent to the publication of the work in any and all Scientific Reports publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"8553"}}